📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-05 13:18
709 analysed today
709
Today
133,598
All-time analysed
40,124
Positive
6,284
Negative
79,370
Neutral
7,752
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
11 announcements match the current filters (relevance ≥ 5).
Diamines & Chemicals Reports ₹0.27 Cr Q1 Profit; Approves ₹40 Cr Investment in Subsidiary
Diamines & Chemicals (DACL) returned to profitability in Q1 FY27, posting a net profit of ₹0.27 Cr compared to a loss of ₹2.39 Cr in the same quarter last year. The Board approved a significant ₹40 Cr additional investment in its wholly-owned subsidiary, DACL Fine Chem Limited, to be funded via internal accruals and liquid funds. This investment is highly material, representing approximately 105% of the company's TTM revenue. While the company's new project has reached mechanical completion, commercial production is currently delayed due to ongoing optimization of the distillation process.
Confidence: HIGH
What changedThe company has moved from a loss-making phase to a marginal profit and has committed a capital amount exceeding its annual revenue into its subsidiary for expansion.
Why it mattersThe ₹40 Cr investment is a major scale-up move for a company with a ₹272 Cr market cap and ₹38 Cr TTM revenue, signaling a pivot toward growth through its subsidiary despite current pricing pressures in the chemicals industry.
Q1 FY27 Revenue: ₹14.37 CrQ1 FY27 Net Profit: ₹0.27 CrSubsidiary Investment: ₹40 CrInvestment vs TTM Revenue: 105.2%Investment vs Net Worth: 24.4%
📅 Short termThe return to profitability and the announcement of a large capital commitment are likely to be viewed positively by the market in the coming weeks.
📈 Long termThe long-term trajectory depends on the successful commissioning of the distillation process and the ability of the subsidiary to generate returns on the ₹40 Cr investment.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Delay in commercial production due to process optimization
- High capital commitment relative to current revenue base
- Global demand-supply imbalance in ethylene amines
Key Highlights
Standalone revenue for Q1 FY27 rose to ₹14.37 Cr from ₹12.23 Cr in Q1 FY26.
Turned profitable with a net profit of ₹0.27 Cr against a loss of ₹2.39 Cr YoY.
Approved ₹40 Cr investment in subsidiary DACL Fine Chem Limited for capital and operational expenditure.
Project update confirms substantial completion of mechanical, electrical, and utility systems, though commercial production is pending.
Discontinued the non-core Trading Division (Fruits & Vegetables) which had zero business activity since last year.
👀 What to Watch
Investors should monitor the timeline for the commencement of commercial production at the new project site and the specific deployment of the ₹40 Cr capital in the subsidiary.
₹40 Cr Land Acquisition for New Chemical Plant by Diamines & Chemicals Subsidiary
DACL Fine Chem Limited, a wholly-owned subsidiary of Diamines & Chemicals, has signed a binding term sheet to acquire approximately 50 acres of freehold industrial land in Kakinada, Andhra Pradesh. The total land consideration is ₹40 crore (₹28 cr for Tranche 1 and ₹12 cr for Tranche 2), which is highly significant as it exceeds the company's TTM revenue of ₹38 crore. The land is intended for a new chemical plant, signaling a major capacity expansion despite the company reporting a TTM PAT loss of ₹13 crore. The term sheet remains valid until June 30, 2027, pending the execution of a definitive agreement.
Confidence: HIGH
What changedThe company has moved from planning to a binding commitment to acquire a large land parcel for a new manufacturing facility through its subsidiary.
Why it mattersThis is a massive scale-up relative to the company's current size; the land cost alone is 24% of its net worth and 105% of annual revenue, indicating a potential structural shift in the business if successfully executed.
Total Land Cost: ₹40 croreLand Cost vs TTM Revenue: ~105%Land Cost vs Net Worth: ~24.4%Land Area: 50 acresTerm Sheet Validity: June 30, 2027
📅 Short termThe market may view the expansion intent positively, but concerns regarding the funding of a ₹40 cr land deal plus plant capex while the company is loss-making may limit immediate upside.
📈 Long termIf the new plant successfully addresses the global demand-supply imbalance mentioned in filings, it could significantly re-rate the company's small revenue base over the next 3-5 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Funding risk for capex given TTM PAT of -₹13 Cr
- Execution risk for a project of this magnitude relative to current operations
- Long lead time for definitive agreement (June 2027)
Key Highlights
Acquisition of approximately 50 acres of freehold industrial land at Auro Industrial Park, Kakinada
Total land consideration of ₹40 crore, comprising ₹28 crore for Tranche 1 and ₹12 crore for Tranche 2
Land cost alone represents ~105% of the company's TTM revenue of ₹38 crore
Binding term sheet is valid for one year until June 30, 2027
Expansion aimed at setting up a new chemical plant to potentially reverse recent revenue declines
👀 What to Watch
Monitor the company's funding strategy for this land purchase and subsequent plant construction, especially given the current negative operating margins (-35.9%) and cash flow constraints.
Diamines & Chemicals Reports Zero Fund Deviation; Significant Warrants Lapse in Q4 FY26
Diamines & Chemicals Limited (DACL) has reported no deviation or variation in the utilization of funds raised through its preferential issue for the quarter ended March 31, 2026. While the company originally planned to raise up to Rs 50.58 crore, only 2,69,402 warrants were converted into equity shares, bringing in Rs 11.15 crore (75% exercise money) in March 2026. The remaining warrants from the original 9,06,390 allotment have lapsed as of the March 31 deadline. The funds received are being directed toward capital expenditure, working capital, and general corporate purposes.
Key Highlights
Confirmed zero deviation in the utilization of funds as per the objects of the preferential issue.
Allotted 2,69,402 equity shares on March 24, 2026, following the receipt of Rs 11.15 crore in exercise money.
The company had previously received Rs 12.51 crore as the initial 25% subscription for 9,06,390 warrants in October 2024.
Remaining warrants lapsed on March 31, 2026, meaning the company did not realize the full potential capital of Rs 50.58 crore.
Funds are earmarked for CAPEX, working capital requirements, and technology investments.
👀 What to Watch
While the lack of fund deviation is positive for corporate governance, investors should monitor if the lapsing of a majority of the warrants affects the company's planned expansion or CAPEX timelines due to lower-than-expected capital inflow.
Diamines & Chemicals Reports FY26 Net Loss and Re-appoints Key Leadership
Diamines & Chemicals Limited approved its audited financial results for the year ended March 31, 2026, which notably reported a net loss. The board has re-appointed Mr. Tanmay Godiawala as Executive Director and Mr. Rajendra Chhabra as Non-Executive Director for three-year terms starting in late 2026 and early 2027. Additionally, the company has overhauled its audit team by appointing new cost, internal, and tax auditors for FY 2026-27. The board also approved a commission-based remuneration structure for non-executive directors for the next five years.
Key Highlights
Audited financial results for FY26 confirmed a net loss for the standalone and consolidated entities.
Mr. Tanmay Godiawala re-appointed as Executive Director for a 3-year term starting February 6, 2027.
Mr. Rajendra Chhabra re-appointed as Professional Non-Executive Director for 3 years starting November 6, 2026.
New auditors appointed for FY27: S S Puranik & Associates (Cost), CNK & Associates LLP (Internal), and K. C. Mehta & Co. LLP (Tax).
Approved remuneration for Rajendra Chhabra exceeding 50% of the total non-executive director compensation pool for FY27 and FY28.
👀 What to Watch
Investors should carefully review the detailed financial statements to identify the drivers behind the reported net loss. Maintain a cautious stance until the company provides a clear outlook for returning to profitability.
Diamines & Chemicals Reports FY26 Net Loss; Re-appoints Key Directors and Auditors
Diamines & Chemicals Limited (DACL) has approved its audited financial results for the fiscal year ended March 31, 2026, which notably reported a net loss for the period. The board has re-appointed Mr. Tanmay Godiawala as Executive Director and Mr. Rajendra Chhabra as Non-Executive Director for three-year terms starting in late 2026 and early 2027. Furthermore, the company has structured a new remuneration plan for Non-Executive Directors involving commissions on net profits for the next five years. New internal, cost, and tax auditors have also been appointed for the 2026-27 financial year.
Key Highlights
Reported a net loss for the standalone financial year ended March 31, 2026, as per the Independent Auditor's Report.
Re-appointed Mr. Tanmay Godiawala as Executive Director for a 3-year term effective February 06, 2027.
Approved commission-based remuneration for all Non-Executive Directors for FY 2026-27 through 2030-31.
Appointed M/s CNK & Associates LLP as Internal Auditors and M/s K. C. Mehta & Co. LLP as Tax Auditors for FY 2026-27.
Proposed remuneration for Mr. Rajendra Chhabra to exceed 50% of the total fees payable to all Non-Executive Directors for FY 2026-27 and 2027-28.
👀 What to Watch
Investors should scrutinize the detailed financial statements to identify the causes of the reported net loss and assess if it is a cyclical or structural issue. The stability in management is positive, but the shift to profit-based commissions for directors during a loss-making period warrants close monitoring.
Diamines & Chemicals Forfeits ₹8.79 Cr as 6.37 Lakh Warrants Lapse
Diamines & Chemicals Limited announced that 6,36,988 convertible warrants have lapsed as holders failed to exercise their conversion option by the March 31, 2026 deadline. Consequently, the company has forfeited the initial 25% subscription amount of ₹8.79 crore (₹138 per warrant). Out of the 9,06,390 warrants originally allotted in October 2024 at an issue price of ₹552, only 2,69,402 were converted into equity. Notably, the promoter group chose not to convert 3,23,388 warrants, which represents a significant portion of the lapsed instruments.
Key Highlights
6,36,988 warrants lapsed out of 9,06,390 initially allotted on October 1, 2024.
Company forfeited ₹8.79 crore, representing the 25% upfront payment for the lapsed warrants.
Promoter group failed to convert 3,23,388 warrants, while non-promoters let 3,13,600 warrants lapse.
The conversion price was set at ₹552 per warrant, and only 29.7% of the total issue was converted.
The company misses out on approximately ₹26.37 crore in anticipated capital from the remaining 75% payment.
👀 What to Watch
Investors should view the promoter's decision not to exercise warrants at ₹552 as a cautious signal regarding the stock's valuation. Monitor the current market price relative to the strike price to understand the lack of conversion interest.
Diamines & Chemicals Receives Disclosure Under SEBI SAST Regulations
Diamines & Chemicals Limited has informed the stock exchanges about a disclosure received under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation mandates disclosure when there is a change in shareholding exceeding 2% or when a promoter's holding changes. The disclosure was received by the company on March 25 and subsequently reported to the BSE and NSE. Such filings are key indicators of significant shifts in ownership or promoter confidence.
Key Highlights
Company received disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations
Notification submitted to BSE (Scrip Code: 500120) and NSE (Symbol: DIAMINESQ) on March 26, 2025
The disclosure pertains to a transaction or change in holding reported on March 25
Regulation 29(2) filings typically involve transactions by promoters or major institutional investors
👀 What to Watch
Investors should check the detailed SAST filing on the exchange websites to identify the specific party involved and whether they were buying or selling. Promoter acquisitions are generally viewed as a positive signal of internal confidence.
Diamines & Chemicals Converts 2.69 Lakh Warrants into Equity; Raises Rs. 11.15 Crore
Diamines & Chemicals Limited has approved the conversion of 2,69,402 warrants into an equal number of equity shares following the receipt of the 75% balance payment. This exercise has resulted in a capital infusion of approximately Rs. 11.15 crore into the company. The conversion was primarily driven by promoter group entities, including the Mehta family and associated companies, indicating strong promoter commitment. Following this allotment, the company's total paid-up equity capital has increased to Rs. 10.05 crore, with 6,36,988 warrants still pending for future conversion.
Key Highlights
Conversion of 2,69,402 warrants into equity shares at a total issue price of Rs. 552 per share.
Receipt of Rs. 11.15 crore representing the 75% balance exercise price (Rs. 414 per warrant).
Promoter group entities dominated the conversion, including Amit Mehta and S Amit Speciality Chemicals.
Total paid-up equity shares increased from 97,83,990 to 1,00,53,392 shares.
6,36,988 warrants remain outstanding and must be converted within 18 months of their original allotment.
👀 What to Watch
The conversion of warrants by promoters at a price of Rs. 552 per share reflects management's confidence in the company's long-term prospects. Investors should monitor the utilization of the newly raised capital and the eventual conversion of the remaining warrants.
Diamines & Chemicals Q3 FY26: Net Loss Widens to ₹192.55 Lakhs as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significant downturn in its Q3 FY26 results, with standalone revenue falling 56.4% YoY to ₹763.57 Lakhs. The company recorded a net loss of ₹192.55 Lakhs for the quarter, a sharp increase from the ₹15.34 Lakhs loss in the previous year's corresponding quarter. For the nine-month period, the company reported a total loss of ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the prior year. The decline is primarily attributed to poor performance in the Specialty Chemicals segment, which saw its segment results turn into a loss.
Key Highlights
Standalone Revenue from Operations fell to ₹763.57 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.
Net loss for the nine months ended Dec 31, 2025, stood at ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the previous year.
Specialty Chemicals segment loss before tax and finance costs was ₹290.20 Lakhs for the quarter.
Total expenses for the quarter were ₹1,139.19 Lakhs, significantly exceeding the total income of ₹835.63 Lakhs.
The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
👀 What to Watch
The sharp decline in revenue and transition to significant losses indicate severe operational headwinds in the specialty chemicals sector. Investors should remain cautious and wait for signs of margin recovery or improved demand before considering any fresh investments.
Diamines & Chemicals Reports Q3 FY26 Net Loss of ₹1.93 Cr as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significantly weak performance for the quarter ended December 31, 2025, posting a standalone net loss of ₹192.55 Lakhs compared to a profit of ₹157.50 Lakhs in the same quarter last year. Revenue from operations plummeted by over 56% YoY to ₹763.87 Lakhs, reflecting severe pressure in its core Specialty Chemicals segment. For the nine-month period ending December 2025, the company has accumulated a net loss of ₹901.97 Lakhs, a sharp reversal from the ₹287.07 Lakhs profit recorded in the previous year's corresponding period. The board also reviewed and approved a revised Related Party Policy during the meeting.
Key Highlights
Revenue from operations fell 56.4% YoY to ₹763.87 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.
Standalone net loss for the quarter stood at ₹192.55 Lakhs versus a net profit of ₹157.50 Lakhs in the prior year period.
Specialty Chemicals segment recorded a loss of ₹290.20 Lakhs before tax and finance costs during the quarter.
Nine-month (9M FY26) revenue declined to ₹2,917.05 Lakhs from ₹5,349.75 Lakhs in 9M FY25.
The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
👀 What to Watch
The sharp decline in revenue and transition to significant losses indicate serious operational or market headwinds for the company's specialty chemicals business. Investors should remain cautious and wait for signs of margin stabilization or a recovery in demand before considering any fresh positions.
Diamines & Chemicals Gets GPCB Approval for Product Mix Amendment to Boost Production Capacity
Diamines & Chemicals Limited has received a Consolidated Consent & Authorization (CC&A) amendment from the Gujarat Pollution Control Board (GPCB) on January 21, 2026. This regulatory approval allows the company to modify its product mix and set up new industrial activities within its existing manufacturing unit in Vadodara. The management expects this move to facilitate the production of new items and contribute to an overall increase in total production capacity. The license is valid until September 30, 2027, providing a clear operational runway for the planned expansion.
Key Highlights
Received CC&A Amendment from Gujarat Pollution Control Board (GPCB) on January 21, 2026
Approval enables setting up of new industrial plant/activities within the existing manufacturing unit
The amendment allows for a revised product mix, leading to an increase in total production capacity
The regulatory license (Order AWH-151692) is valid for a period ending September 30, 2027
👀 What to Watch
Investors should view this as a positive step toward volume growth and monitor the company's timeline for the commencement of new product manufacturing.
